Every weekday morning

The Daily Signal

One story that matters in health technology, chosen and written by the desk, with an audio version for the commute.

• 
  October 9

  FDA Approves Genentech's Tecentriq for Stage III dMMR Colon Cancer

• 
  October 8

  FDA Approves Tucatinib Combination for HER2-Positive Breast Cancer Maintenance

• 
  October 7

  FDA Clearance of Motivista Shifts Focus to Schizophrenia's Unresolved Symptoms

• 
  October 5

  Edwards Lifesciences Wins FDA Approval for Size-Adjustable Pediatric Heart Valve

• 
  October 1

  Ceribell Receives FDA Clearance for Point-of-Care Brain Monitoring Software

• 
  September 30

  FDA Clears Cepheid's 13-Pathogen Respiratory Panel